Search

Search Results

• 

  Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy

  Mafalda Miranda Baleiras, Luís Maduro, Carolina Vasques, Filipa Ferreira, Marta Mesquita Pinto, Ana Martins

  29-07-2021

  https://doi.org/10.4081/dr.2021.9262

  2234

  PDF: 617

  HTML: 28
• 

  Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

  Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

  16-03-2015

  https://doi.org/10.4081/dr.2015.5804

  2841

  PDF: 1170

  HTML: 252

• Discoid lupus erythematosus associated with chronic granulomatous disease

  Ana Carolina de Almeida Figueiredo, Ana Luísa Matos, Joana Calvão, José Carlos Cardoso

  13-09-2023

  https://doi.org/10.4081/dr.2023.9837

  972

  PDF: 485

  HTML: 24
• 

  Acral pityriasis rosea: A rare variant of pityriasis rosea

  Pimpa Tantanasrigul, Mingkwan Wichaidit, Preya Kullavanijaya

  13-05-2021

  https://doi.org/10.4081/dr.2021.9081

  2881

  PDF: 698

  HTML: 1158

• 12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni¹, L. Eichenfield², J. Ornelas³, V. Prajapati⁴, C. Yang⁵, A. Tanaka⁶, S. Weidinger⁷, C. Flohr⁸, E. Swanson⁹, L. Martin¹⁰, S. Daveiga¹¹, R. Gontijo Lima¹¹, H. Elmaraghy¹¹, E. Pierce¹¹, P. Sen¹¹, G. Gallo¹¹, M. Piruzeli¹¹, A. Larkin¹¹, M. Grau¹², Y. Mihaylov¹², A. Paller¹³ | ¹Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; ²Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; ³Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; ⁴Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; ⁵Chang Gung University College of Medicine, Taoyuan, TW; ⁶Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; ⁷Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; ⁸Department of Dermatology and Population Health Sciences, King’s College London, London, UK; ⁹Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; ¹⁰School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; ¹¹Eli Lilly and Company, Indianapolis, Indiana,US; ¹²Almirall R&D, S.A., Barcelona, ES; ¹³Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11079

  196

  PDF: 44

• A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

  Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  06-06-2023

  https://doi.org/10.4081/dr.2023.9722

  858

  PDF: 488

  HTML: 27
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  https://doi.org/10.4081/dr.2017.7079

  1453

  PDF: 691

  HTML: 149